Cargando…

Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance

BACKGROUND: Identification of genes whose basal mRNA expression predicts the sensitivity of tumor cells to cytotoxic treatments can play an important role in individualized cancer medicine. It enables detailed characterization of the mechanism of action of drugs. Furthermore, screening the expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emad, Amin, Cairns, Junmei, Kalari, Krishna R., Wang, Liewei, Sinha, Saurabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554409/ https://www.ncbi.nlm.nih.gov/pubmed/28800781 http://dx.doi.org/10.1186/s13059-017-1282-3

Ejemplares similares

Principled multi-omic analysis reveals gene regulatory mechanisms of phenotype variation
por: Hanson, Casey, et al.
Publicado: (2018)

CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer
por: Cairns, Junmei, et al.
Publicado: (2020)

Identification of pathways associated with chemosensitivity through network embedding
por: Wang, Sheng, et al.
Publicado: (2019)

Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer
por: Athreya, Arjun P., et al.
Publicado: (2017)

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1
por: Cairns, Junmei, et al.
Publicado: (2019)

Knowledge-guided analysis of "omics" data using the KnowEnG cloud platform
por: Blatti, Charles, et al.
Publicado: (2020)

Inference of phenotype-relevant transcriptional regulatory networks elucidates cancer type-specific regulatory mechanisms in a pan-cancer study
por: Emad, Amin, et al.
Publicado: (2021)

Bora Downregulation Results in Radioresistance by Promoting Repair of Double Strand Breaks
por: Cairns, Junmei, et al.
Publicado: (2015)

Tissue-guided LASSO for prediction of clinical drug response using preclinical samples
por: Huang, Edward W., et al.
Publicado: (2020)

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early‐Stage Breast Cancer
por: Cairns, Junmei, et al.
Publicado: (2021)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Insights into Chemoresistance of Prostate Cancer
por: Zhang, Wei, et al.
Publicado: (2015)

Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
por: Tong, Yin, et al.
Publicado: (2015)

Cell-level somatic mutation detection from single-cell RNA sequencing
por: Vu, Trung Nghia, et al.
Publicado: (2019)

SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1
por: Cairns, Junmei, et al.
Publicado: (2017)

Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation
por: Cairns, Junmei, et al.
Publicado: (2018)

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
por: Ali, Ahmed Y, et al.
Publicado: (2012)

Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)

Alternating EM algorithm for a bilinear model in isoform quantification from RNA-seq data
por: Deng, Wenjiang, et al.
Publicado: (2019)

FKBP5 as a Selection Biomarker for Gemcitabine and Akt Inhibitors in Treatment of Pancreatic Cancer
por: Hou, Junmei, et al.
Publicado: (2012)

Isoform-level gene expression patterns in single-cell RNA-sequencing data
por: Vu, Trung Nghia, et al.
Publicado: (2018)

SLCO1B1: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function
por: Zhang, Lingxin, et al.
Publicado: (2021)

Versatile knowledge guided network inference method for prioritizing key regulatory factors in multi-omics data
por: Ogris, Christoph, et al.
Publicado: (2021)

The molecular mechanisms of chemoresistance in cancers
por: Zheng, Hua-Chuan
Publicado: (2017)

Early Mechanisms of Chemoresistance in Retinoblastoma
por: Zhang, Michelle G., et al.
Publicado: (2022)

Systematic integration of biomedical knowledge prioritizes drugs for repurposing
por: Himmelstein, Daniel Scott, et al.
Publicado: (2017)

Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance
por: Zong, Xuan, et al.
Publicado: (2021)

Integrating ‘Omics’ Approaches to Prioritize New Pathogenetic Mechanisms for Mental Disorders
por: Cattaneo, Annamaria, et al.
Publicado: (2018)

Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas
por: Chen, Jungang, et al.
Publicado: (2019)

Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance
por: Genovese, Ilaria, et al.
Publicado: (2021)

Copy number variation and cytidine analogue cytotoxicity: A genome-wide association approach
por: Kalari, Krishna R, et al.
Publicado: (2010)

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
por: Li, Liang, et al.
Publicado: (2014)

Circular RNAs and their associations with breast cancer subtypes
por: Nair, Asha A., et al.
Publicado: (2016)

A network-based phenotype mapping approach to identify genes that modulate drug response phenotypes
por: Cairns, Junmei, et al.
Publicado: (2016)

Testis- specific Y-encoded- like protein 1 and cholesterol metabolism: Regulation of CYP1B1 expression through Wnt signaling
por: Zhu, Xiujuan, et al.
Publicado: (2022)

Biofilm formation by Bacillus subtilis: new insights into regulatory strategies and assembly mechanisms
por: Cairns, Lynne S, et al.
Publicado: (2014)

Mechanisms of chemoresistance in cancer stem cells
por: Abdullah, Lissa Nurrul, et al.
Publicado: (2013)

Molecular mechanisms of chemoresistance in osteosarcoma (Review)
por: HE, HONGTAO, et al.
Publicado: (2014)

Molecular mechanisms of chemoresistance in gastric cancer
por: Shi, Wen-Jia, et al.
Publicado: (2016)

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
por: Luo, Yuchun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3mulqk4u3hmtqgiscfth939c8d